Machine Learning in oncology: A clinical appraisal
- PMID: 32251707
- DOI: 10.1016/j.canlet.2020.03.032
Machine Learning in oncology: A clinical appraisal
Abstract
Machine learning (ML) is a branch of artificial intelligence centered on algorithms which do not need explicit prior programming to function but automatically learn from available data, creating decision models to complete tasks. ML-based tools have numerous promising applications in several fields of medicine. Its use has grown following the increased availability of patient data due to technological advances such as digital health records and high-volume information extraction from medical images. Multiple ML algorithms have been proposed for applications in oncology. For instance, they have been employed for oncological risk assessment, automated segmentation, lesion detection, characterization, grading and staging, prediction of prognosis and therapy response. In the near future, ML could become essential part of every step of oncological screening strategies and patients' management thus leading to precision medicine.
Keywords: Artificial intelligence; Deep learning; Machine learning; Precision oncology; Radiogenomics.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest None.
Similar articles
-
Artificial Intellgence in the Era of Precision Oncological Imaging.Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221141793. doi: 10.1177/15330338221141793. Technol Cancer Res Treat. 2022. PMID: 36426565 Free PMC article. Review.
-
Precision Psychiatry Applications with Pharmacogenomics: Artificial Intelligence and Machine Learning Approaches.Int J Mol Sci. 2020 Feb 1;21(3):969. doi: 10.3390/ijms21030969. Int J Mol Sci. 2020. PMID: 32024055 Free PMC article. Review.
-
[Basis and perspectives of artificial intelligence in radiation therapy].Cancer Radiother. 2019 Dec;23(8):913-916. doi: 10.1016/j.canrad.2019.08.005. Epub 2019 Oct 20. Cancer Radiother. 2019. PMID: 31645301 French.
-
Artificial Intelligence in Oncological Hybrid Imaging.Rofo. 2023 Feb;195(2):105-114. doi: 10.1055/a-1909-7013. Epub 2022 Sep 28. Rofo. 2023. PMID: 36170852 Review. English.
-
Artificial intelligence in digital pathology - new tools for diagnosis and precision oncology.Nat Rev Clin Oncol. 2019 Nov;16(11):703-715. doi: 10.1038/s41571-019-0252-y. Epub 2019 Aug 9. Nat Rev Clin Oncol. 2019. PMID: 31399699 Free PMC article. Review.
Cited by
-
Artificial Intelligence in Breast Imaging: Opportunities, Challenges, and Legal-Ethical Considerations.Eurasian J Med. 2023 Dec;55(1):114-119. doi: 10.5152/eurasianjmed.2023.23360. Eurasian J Med. 2023. PMID: 39128072 Free PMC article.
-
Effects of Interobserver Variability on 2D and 3D CT- and MRI-Based Texture Feature Reproducibility of Cartilaginous Bone Tumors.J Digit Imaging. 2021 Aug;34(4):820-832. doi: 10.1007/s10278-021-00498-3. Epub 2021 Aug 17. J Digit Imaging. 2021. PMID: 34405298 Free PMC article.
-
Identification of the new molecular subtypes related to inflammation in breast cancer.Medicine (Baltimore). 2024 May 10;103(19):e38146. doi: 10.1097/MD.0000000000038146. Medicine (Baltimore). 2024. PMID: 38728446 Free PMC article.
-
Deep learning radiomic nomogram outperforms the clinical model in distinguishing intracranial solitary fibrous tumors from angiomatous meningiomas and can predict patient prognosis.Eur Radiol. 2025 May;35(5):2670-2680. doi: 10.1007/s00330-024-11082-y. Epub 2024 Oct 16. Eur Radiol. 2025. PMID: 39412667
-
Machine learning-based CT radiomics features for the prediction of pulmonary metastasis in osteosarcoma.Br J Radiol. 2021 Aug 1;94(1124):20201391. doi: 10.1259/bjr.20201391. Epub 2021 Jun 19. Br J Radiol. 2021. PMID: 34111978 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources